Investigating the role of TIGD1 in lung cancer
Author Information
Author(s): BAL ALBAYRAK Merve Gülsen, KORAK Tuğcan, KASAP Murat, AKPINAR Gürler
Primary Institution: Kocaeli University
Hypothesis
The study aims to elucidate the biological functions, associated pathways, and interacting proteins of TIGD1 in lung cancer.
Conclusion
The study identifies potential biomarker candidates associated with TIGD1 gene expression, which may serve as therapeutic targets for lung cancer.
Supporting Evidence
- TIGD1 was found to be upregulated in various cancers, including lung squamous cell carcinoma.
- The study identified 13 upregulated and 1 downregulated differentially expressed genes.
- Hub genes identified include AKT1, BRAF, SRC, and TP53, which are central regulators of cell proliferation and apoptosis.
- Significant involvement of TIGD1-associated DEGs in crucial molecular pathways was revealed.
Takeaway
Researchers looked at a gene called TIGD1 to see how it might help doctors find new ways to treat lung cancer.
Methodology
The study analyzed the GSE229260 microarray dataset to identify differentially expressed genes in TIGD1-silenced A549 lung cancer cells and performed enrichment analyses and protein–protein interaction network construction.
Limitations
The study is based on a single dataset and a limited number of samples, focusing primarily on A549 lung cancer cells.
Statistical Information
P-Value
0.0010
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website